Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.

Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion.

Tipples K, Kolluri RB, Raouf S.

J Oncol Pharm Pract. 2009 Dec;15(4):237-9. doi: 10.1177/1078155209102511. Epub .

PMID:
19276137
[PubMed - indexed for MEDLINE]
2.
3.

Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report.

Fantini M, Gianni L, Tassinari D, Nicoletti S, Possenti C, Drudi F, Sintini M, Bagli L, Tamburini E, Ravaioli A.

J Oncol Pharm Pract. 2011 Sep;17(3):288-91. doi: 10.1177/1078155210374891. Epub 2010 Oct 6. Review.

PMID:
20926454
[PubMed - indexed for MEDLINE]
4.

Capecitabine-induced cerebellar toxicity in a patient with metastatic colorectal cancer.

Gounaris I, Ahmad A.

J Oncol Pharm Pract. 2010 Dec;16(4):277-9. doi: 10.1177/1078155209349201. Epub 2009 Oct 15.

PMID:
19833683
[PubMed - indexed for MEDLINE]
5.

[Late-onset leukoencephalopathy induced by long-term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer].

Yasaki S, Tukamoto Y, Yuasa N, Ishikawa T, Yoshii F.

Rinsho Shinkeigaku. 2012;52(4):251-6. Japanese.

PMID:
22531658
[PubMed - indexed for MEDLINE]
6.

Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.

Starling N, Rao S, Cunningham D, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR.

J Clin Oncol. 2009 Aug 10;27(23):3786-93. doi: 10.1200/JCO.2008.19.4274. Epub 2009 Apr 27.

PMID:
19398575
[PubMed - indexed for MEDLINE]
Free Article
7.

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma.

Starling N, Okines A, Cunningham D, Allum W, Wotherspoon A, Benson M, Thompson J, Thomas J, Brown G, Riddell A, Stavridi F, Ashley S, Oates J, Chau I.

Br J Cancer. 2009 Jun 2;100(11):1725-30. doi: 10.1038/sj.bjc.6605070. Epub 2009 May 12.

PMID:
19436301
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[Severe toxicity following capecitabine administration because of dihydropyrimidine deshydrogenase (DPD) deficiency].

Coursier S, Martelet S, Guillermet A, Emptoz J, Villier C, Bontemps H.

Gastroenterol Clin Biol. 2010 Mar;34(3):218-23. doi: 10.1016/j.gcb.2009.08.014. Epub 2010 Mar 10. French.

PMID:
20219304
[PubMed - indexed for MEDLINE]
Free Article
9.

A case of capecitabine-induced coronary microspasm in a patient with rectal cancer.

Arbea L, Coma-Canella I, Martinez-Monge R, García-Foncillas J.

World J Gastroenterol. 2007 Apr 14;13(14):2135-7.

PMID:
17465463
[PubMed - indexed for MEDLINE]
Free Article
10.

Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma.

Corporaal S, Smit WM, Russel MG, van der Palen J, Boot H, Legdeur MC.

Neth J Med. 2006 May;64(5):141-6.

PMID:
16702612
[PubMed - indexed for MEDLINE]
Free Article
11.

A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma.

Evans TR, Pentheroudakis G, Paul J, McInnes A, Blackie R, Raby N, Morrison R, Fullarton GM, Soukop M, McDonald AC.

Ann Oncol. 2002 Sep;13(9):1469-78.

PMID:
12196374
[PubMed - indexed for MEDLINE]
Free Article
12.

Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.

Lee JJ, Kim TM, Yu SJ, Kim DW, Joh YH, Oh DY, Kwon JH, Kim TY, Heo DS, Bang YJ, Kim NK.

Jpn J Clin Oncol. 2004 Jul;34(7):400-4.

PMID:
15342667
[PubMed - indexed for MEDLINE]
Free Article
13.

Safety of capecitabine: a review.

Mikhail SE, Sun JF, Marshall JL.

Expert Opin Drug Saf. 2010 Sep;9(5):831-41. doi: 10.1517/14740338.2010.511610. Review.

PMID:
20722491
[PubMed - indexed for MEDLINE]
14.

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, Bugat R, Findlay M, Frings S, Jahn M, McKendrick J, Osterwalder B, Perez-Manga G, Rosso R, Rougier P, Schmiegel WH, Seitz JF, Thompson P, Vieitez JM, Weitzel C, Harper P; Xeloda Colorectal Cancer Study Group.

J Clin Oncol. 2001 Nov 1;19(21):4097-106.

PMID:
11689577
[PubMed - indexed for MEDLINE]
Free Article
15.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR; Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom.

N Engl J Med. 2008 Jan 3;358(1):36-46. doi: 10.1056/NEJMoa073149.

PMID:
18172173
[PubMed - indexed for MEDLINE]
Free Article
16.

Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.

Norman G, Rice S, Spackman E, Stirk L, Danso-Appiah A, Suh D, Palmer S, Eastwood A.

Health Technol Assess. 2011 May;15 Suppl 1:33-42. doi: 10.3310/hta15suppl1/04. Review.

PMID:
21609651
[PubMed - indexed for MEDLINE]
Free Article
17.

Toxic encephalopathy induced by capecitabine.

Niemann B, Rochlitz C, Herrmann R, Pless M.

Oncology. 2004;66(4):331-5.

PMID:
15218302
[PubMed - indexed for MEDLINE]
18.

[Efficacy and safety of regimens of capecitabine-based chemotherapy in the treatment of advanced breast cancer].

Huang HY, Jiang ZF, Wang T, Zhang SH, Bian L, Cao Y, Wu SK, Song ST.

Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):850-3. Chinese.

PMID:
22335952
[PubMed - indexed for MEDLINE]
19.

[Efficiency of the capecitabine in patients with breast cancer with liver metastasis].

Gasanzade DA, Zeĭnalov RS, Musaev IN.

Georgian Med News. 2009 Jul-Aug;(172-173):13-6. Russian.

PMID:
19644181
[PubMed - indexed for MEDLINE]
20.

Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study.

Rao S, Starling N, Cunningham D, Sumpter K, Gilligan D, Ruhstaller T, Valladares-Ayerbes M, Wilke H, Archer C, Kurek R, Beadman C, Oates J.

Ann Oncol. 2010 Nov;21(11):2213-9. doi: 10.1093/annonc/mdq247. Epub 2010 May 23.

PMID:
20497967
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk